The expression of TOP2A has also been demonstrated in breast, colon, ovarian, and small cell lung cancers as a valuable prognostic marker for tumor advancements and recurrences, and as a predictor of poor survival. The gene discussed is TOP2A; the disease is small cell lung carcinoma.